Cegedim (ALCGM.PA) Stock Analysis & Winston Score
Cegedim is a French technology company that builds software and data tools for the healthcare industry. Its main customers are doctors, pharmacies, insurance companies, and pharmaceutical firms across Europe. The company is best known in France for its medical practice management software and one of the largest databases of healthcare professional contact information on the continent. Cegedim earns most of its revenue through software subscriptions and data licensing fees, giving it a recurring revenue base. It operates primarily in France but also has a presence in the UK, Romania, and other European markets, with annual revenue around €600 million. Its long-standing relationships with healthcare providers and proprietary data assets create some switching costs, but the very thin operating margin of under 2% signals that competition and high operating costs are a persistent challenge — and improving profitability, rather than top-line growth, is the central test the business faces in the near term.
Winston Score: 26/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (13/30)
- Growth: Weak (4/20)
- Cash Flow: Weak (1/10)
- Stability: Mixed (3/10)
- Valuation: Data not available (0/10)
- Ownership: Ownership data not available (not counted) (0/15)
Key Facts
Price: €10.38
Market Cap: €143M
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Exchange: Euronext Paris


